2023
DOI: 10.1016/j.cmi.2023.05.015
|View full text |Cite
|
Sign up to set email alerts
|

Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…All isolates of our most prevalent ST225-II and ST2883-II carried resistance genes against erythromycin and exhibited phenotypic resistance. Macrolide, ciprofloxacin, and mupirocin resistance phenotypes were described as biomarkers of epidemiological success in a recent study by Baede et al, whereas gentamicin resistance was associated with sporadicity [ 33 ]. These observations are consistent with our results.…”
Section: Discussionmentioning
confidence: 99%
“…All isolates of our most prevalent ST225-II and ST2883-II carried resistance genes against erythromycin and exhibited phenotypic resistance. Macrolide, ciprofloxacin, and mupirocin resistance phenotypes were described as biomarkers of epidemiological success in a recent study by Baede et al, whereas gentamicin resistance was associated with sporadicity [ 33 ]. These observations are consistent with our results.…”
Section: Discussionmentioning
confidence: 99%
“…In the United Kingdom, MRSA exhibited higher resistance proportions to fluoroquinolones, erythromycin, gentamicin, moxifloxacin, tobramycin and methicillin. However, the resistance rate to tetracycline was relatively low ( Baede et al, 2023 ). The finding of this study confirmed that MRSA in Chinese county-level hospitals had a higher resistance rate to ERY, but were more sensitive to LNZ and VAN.…”
Section: Discussionmentioning
confidence: 99%
“…ST225-IIa and ST5-IIa isolates were all resistant to erythromycin and ciprofloxacin, which has been identified as a marker for the success of different MRSA clones in France, the Netherlands, and the United Kingdom. MRSA incidence was found to correlate with the total consumption of these antibiotics in the community ( 17 ). In Slovenia, consumption, measured in DDDs per 1,000 inhabitants per day, is right between France and the Netherlands ( 33 ) and both parameters, MRSA incidence from blood cultures and consumption of quinolones and macrolides in community, have been stable for the last 10 years ( 18 , 33 ).…”
Section: Discussionmentioning
confidence: 99%
“…Generally, it is not well understood which group of isolates or their combinations are the most informative to better understand MRSA epidemiology. Furthermore, without a unified sampling system, the comparison of data and identification of the drivers of success of different clones are not possible ( 17 ).…”
Section: Introductionmentioning
confidence: 99%